In vitro inhibition of HIV-1 by Met-SDF-1β alone or in combination with antiretroviral drugs

Antiviral Therapy

Volumn 5, Issue 3, 2000, Pages 199-204

  Rusconi, S ^a   Merrill, D P ^a   La Seta Catamancio, S ^a   Citterio, P ^a   Bulgheroni, E ^a   Croce, F ^a   Chou, T C ^a   Yang, O O ^a   Herrmann, S H ^a   Galli, M ^a   Hirsch, M S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CXCR4; EFAVIRENZ; METHIONINE STROMAL CELL DERIVED FACTOR 1BETA; NELFINAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; IN VITRO STUDY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STROMA CELL; VIRUS ISOLATION;

ANTI-HIV AGENTS; CHEMOKINES, CXC; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; METHIONINE; NELFINAVIR; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0033773544     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Viral dinamics in human immunodeficiency virus type 1 infection
2. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
3. Macrophages as a source of HIV during opportunistic infections
4. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrahe, G protein-coupled receptor
5. Chemokine receptors as HIV-1 coreceptors: Role in viral entry, tropism and disease
6. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
7. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
8. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines
9. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha
10. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
11. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
12. Identification of a major co-receptor for primary isolates of HIV-1
13. + cells is mediated by the chemokine receptor CC-CKR-5
14. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
15. Chemokine receptor regulation and HIV type 1 tropism in monocyte/macrophages
16. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression
17. Expanded tropism of human immunodeficiency virus by a trans-receptor mechanism
18. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
19. HIV infection is blocked in vitro by recombinant soluble CD4
20. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates
21. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
22. Chemokines and HIV infection
23. Chemokine receptors: Keys to AIDS pathogenesis?
24. HIV entry and its inhibition
25. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1 b correlates with down-modulation of CXCR4
26. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-a A inhibit replication of zidovudine resistant human immunodeficiency virus type 1 synergistically in vitro
27. Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates
28. Endpoint methods - Measurements of the infectious titer of a viral sample
29. Effective inhibition of HIV-1 isolated from patients with acute primary infection by aminooxypentane (AOP)-RANTES
30. Quantitative analysis of dose effect relationships: The combined effect of multiple drugs or enzyme inhibitors
31. The median-effect principle and the combination index for quantitation of synergism and antagonism
32. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4
33. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
34. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection
35. A small molecule inhibitor directed against chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
36. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
37. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
38. Strong in vitro synergy observed between the fusion inhibitor T-20 and a CXCR4 blocker, AMD-3100
39. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
40. HIV-1 isolates from patients treated with T-20 are sensitive to the second generation fusion inhibitor T1249
41. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
42. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinational libraries of non-natural binding elements